Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia

Published:2015-06-22 Issue:3 Volume:96 Page:276-284
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Šálek Cyril¹,Folber František²,Froňková Eva³,Procházka Bohumír¹,Marinov Iuri¹,Cetkovský Petr¹,Mayer Jiří²,Doubek Michael²,

Affiliation:

1. Institute of Hematology and Blood Transfusion; Prague Czech Republic

2. Department of Internal Medicine, Hematology and Oncology; University Hospital Brno; Brno Czech Republic

3. Department of Pediatric Hematology and Oncology; 2nd Faculty of Medicine; Charles University and University Hospital Motol; Prague Czech Republic

Funder

MSMT

Ministerstvo Zdravotnictví Ceské Republiky

University Hospital Motol Prague

Czech Leukemia Study Group - for Life

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12587/fullpdf

Reference25 articles.

1. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study;Huguet;J Clin Oncol,2009

2. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802;Stock;Cancer,2013

3. Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study;Tanguy-Schmidt;Biol Blood Marrow Transplant,2013

4. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia;Fielding;Blood,2014

5. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia;Brüggemann;Blood,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative;Asia-Pacific Journal of Clinical Oncology;2023-12-26

2. Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study;Journal of Clinical Oncology;2023-12-14

3. SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances;Frontiers in Oncology;2023-10-16

4. CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia;Biomolecules and Biomedicine;2023-05-14

5. Stem Cell Transplant for Acute Lymphoblastic Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3